Q2

Indo Us Bio-Tech Ltd

INDOUSFY2614 Nov 2025

Revenue+0.3%

Net Profit-26.6%

OPM13.50%

P&L

Quarterly Standalone

Revenue

+0.3%30.85

Expenditure

+5.3%27.31

Net Profit

-26.6%3.45

NPM 11.18%-26.8%EPS ₹1.72-26.8%

vs Q1 FY26

Informational and educational content only. Not investment advice.